ArticleCell cycle (Georgetown, Tex.)2016

Silencing of CDK2, but not CDK1, separates mitogenic from anti-apoptotic signaling, sensitizing p53 defective cells for synthetic lethality.

Tatyana S Nekova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.